Acquisition of ICU-acquired weaknessA | ||
---|---|---|
Odd ratio (95% CI) | p value | |
Role of serum cholesterol | ||
Serum cholesterol day 3/LD (per mg/l added) | 0.94 (0.89–1.00) | 0.05 |
Randomization to late-PNB | 0.69 (0.47–1.00) | 0.05 |
Baseline risk factors | ||
Age (per year added) | 1.01 (1.00–1.03) | 0.005 |
Male gender | 0.84 (0.57–1.24) | 0.4 |
BMI (25–40 kg/m2) | 0.83 (0.55–1.23) | 0.3 |
NRS ≥ 5 | 1.41 (0.92–2.16) | 0.1 |
APACHE II (per unit added) | 1.10 (1.07–1.13) | < 0.0001 |
Presence of diabetes | 0.72 (0.41–1.23) | 0.2 |
Presence of malignancy | 0.90 (0.57–1.42) | 0.6 |
Pre-admission dialysis | 2.15 (0.35–13.29) | 0.3 |
Sepsis upon admission | 2.26 (1.42–3.59) | 0.0005 |
Admission categories (compared with medical ICU) | ||
Surgical ICU, emergency | 0.68 (0.39–1.16) | 0.1 |
Surgical ICU, elective | 1.83 (0.61–5.45) | 0.2 |
Cardiac surgery | 1.84 (0.90–3.75) | 0.09 |
Impact of statin therapy | ||
Statin therapy | 0.66 (0.40–1.08) | 0.1 |
Serum cholesterol day 3/LD (per mg/l added) | 0.94 (0.89–0.99) | 0.03 |
Randomization to late-PNB | 0.68 (0.46–0.99) | 0.04 |
Baseline risk factors | ||
Age (per year added) | 1.02 (1.00–1.03) | 0.002 |
Male gender | 0.86 (0.58–1.27) | 0.4 |
BMI (25–40 kg/m2) | 0.86 (0.58–1.29) | 0.4 |
NRS ≥ 5 | 1.45 (0.94–2.23) | 0.08 |
APACHE II (per unit added) | 1.10 (1.07–1.13) | < 0.0001 |
Presence of diabetes | 0.79 (0.45–1.37) | 0.4 |
Presence of malignancy | 0.89 (0.57–1.41) | 0.6 |
Pre-admission dialysis | 2.06 (0.33–12.58) | 0.4 |
Sepsis upon admission | 0.44 (0.28–0.70) | 0.0006 |
Admission categories (compared with medical ICU) | ||
Surgical ICU, emergency | 0.71 (0.41–1.23) | 0.2 |
Surgical ICU, elective | 1.83 (0.61–5.46) | 0.2 |
Cardiac surgery | 2.04 (1.00–4.20) | 0.05 |